Aktinos Pharma

Hyderabad, India Founded: 2007 • Age: 19 yrs
Offers integrated scientific services for RD and manufacturing in pharmaceuticals sector.

About Aktinos Pharma

Aktinos Pharma is a Healthcare company based in Hyderabad (India) founded in 2007. It offers integrated scientific services for RD and manufacturing in pharmaceuticals sector. It operates on a B2B model. The company has 411 employees. Its Indian entity Aktinos Pharma Private Limited reported revenue of β‚Ή208 Cr. Aktinos Pharma offers products and services including API and Intermediates. Its focus areas include Healthcare and Life Sciences, Pharmaceuticals, Contract Research and Manufacturing and API Production. Its competitors include Viyash, Inventys and Blue Jet Healthcare; 2 of its 3 listed competitors have raised funding.

Company details

Aktinos Pharma is a contract research, development, and manufacturing organization that delivers customized end-to-end solutions from early discovery to commercial supply. They focus on fulfilling client RD and manufacturing needs through collaborations, supported by experienced scientists and facilities in Hyderabad, India. The company serves various clients with high-quality API and intermediates, emphasizing innovation and quality in operations.

  • Headquarters Hyderabad, India
  • Employees 411
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website aktinos.in
  • Legal Name Aktinos Pharma Private Limited
  • Date of Incorporation 13 Sep, 2007
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹208 Cr

    FY 2024 · +18% YoY

  • Net Loss
    -₹7.16 Cr

    FY 2024 · -3% margin

  • EBITDA
    ₹7.12 Cr

    FY 2024 · 3% margin

  • Employee Count
    411

Products & Services of Aktinos Pharma

Aktinos Pharma offers a comprehensive portfolio of products and services, including API and Intermediates.

API
Pharmaceutical Products

Active pharmaceutical ingredients for drug manufacturing and supply.

Intermediates
Chemical Intermediates

Raw materials used in API production for research and manufacturing.

Board of directors of Aktinos Pharma Private Limited (Aktinos Pharma)

Aktinos Pharma Private Limited is the primary company behind Aktinos Pharma. The board of Aktinos Pharma Private Limited currently have 4 directors; the longest-serving is Srilakshmi Madala, appointed in 2007. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Srilakshmi Madala
DIN 01746196
Whole-time director13 Sep 200719 yrs 1 moAktinos Pharma Private Limited
Murali Krishna Madala
DIN 00928526
Managing Director13 Sep 200719 yrs 1 moAktinos Pharma Private Limited
Ravishanker Kovi
DIN 00278107
Director24 Jul 20179 yrs 3 moAktinos Pharma Private Limited
Vineeth Madala
DIN 09534028
Director01 Aug 20224 yrs 3 moAktinos Pharma Private Limited

Financials of Aktinos Pharma

Figures of Aktinos Pharma Private Limited, the primary company behind Aktinos Pharma, for FY 2024. Revenue was ₹208 Cr (+18% year on year). Net loss was -₹7.16 Cr (-3% margin). EBITDA was ₹7.12 Cr (3% margin). Revenue has grown at a compounded annual rate of +4896% over three years and +8% over five years.

  • ₹208 CrRevenue · FY 2024 · +18% YoY
  • -₹7.16 CrNet loss · -3% margin
  • ₹7.12 CrEBITDA · 3% margin
  • ₹4.03 CrPaid-up capital
  • 411Employees (provident fund records)
  • +4896%Revenue CAGR, 3 years
  • +8%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Aktinos Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Aktinos Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Aktinos Pharma

Aktinos Pharma has 3 listed competitors in our database, 2 of them funded. They include Viyash, Inventys and Blue Jet Healthcare.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
viyash.com2019Hyderabad, India$120.02M277
APIs and intermediates are manufactured by Viyash as a CDMO.
inventys.in2005Mumbai, India$64.34M219
Actives, advanced intermediates, and specialty chemicals are custom manufactured.
bluejethealthcare.com1969Mumbai, India476
CDMO focused on manufacturing, supplier, and development of intermediates & APIs
Premium access

Detailed competitors of Aktinos Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Aktinos Pharma

Aktinos Pharma was founded in 2007.

Aktinos Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Aktinos Pharma has 411 employees.

The primary company behind Aktinos Pharma, Aktinos Pharma Private Limited, reported revenue of β‚Ή208 Cr for FY 2024, up 18% year on year.

Aktinos Pharma is a contract research, development, and manufacturing organization that delivers customized end-to-end solutions from early discovery to commercial supply. They focus on fulfilling client RD and manufacturing needs through collaborations, supported by experienced scientists and facilities in Hyderabad, India. The company serves various clients with high-quality API and intermediates, emphasizing innovation and quality in operations.

Aktinos Pharma's top competitors include Inventys, Viyash and Blue Jet Healthcare.

Aktinos Pharma offers API and Intermediates.

Aktinos Pharma operates through Aktinos Pharma Private Limited.

The legal entities of Aktinos Pharma currently have 4 directors, including Srilakshmi Madala, Murali Krishna Madala, Ravishanker Kovi and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available